ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 139 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $670,591 | -13.5% | 453,102 | -5.9% | 0.00% | 0.0% |
| Q2 2023 | $775,609 | -70.6% | 481,745 | -47.1% | 0.00% | -50.0% |
| Q1 2023 | $2,642,536 | -21.4% | 911,219 | -11.1% | 0.00% | -33.3% |
| Q4 2022 | $3,363,371 | -31.0% | 1,025,418 | -20.5% | 0.00% | 0.0% |
| Q3 2022 | $4,875,000 | -39.4% | 1,289,631 | +24.8% | 0.00% | -50.0% |
| Q2 2022 | $8,051,000 | +0.2% | 1,033,544 | +19.5% | 0.01% | +20.0% |
| Q1 2022 | $8,037,000 | -49.7% | 865,144 | -14.6% | 0.01% | -44.4% |
| Q4 2021 | $15,969,000 | +229.4% | 1,013,279 | +274.1% | 0.01% | +200.0% |
| Q3 2021 | $4,848,000 | -27.4% | 270,849 | -36.9% | 0.00% | -25.0% |
| Q2 2021 | $6,676,000 | +8.6% | 429,344 | +0.3% | 0.00% | 0.0% |
| Q1 2021 | $6,149,000 | -75.2% | 428,216 | -66.1% | 0.00% | -73.3% |
| Q4 2020 | $24,808,000 | +991.4% | 1,263,785 | +620.6% | 0.02% | +1400.0% |
| Q3 2020 | $2,273,000 | -30.7% | 175,371 | -22.0% | 0.00% | -66.7% |
| Q2 2020 | $3,278,000 | +79.0% | 224,964 | +4.6% | 0.00% | +50.0% |
| Q1 2020 | $1,831,000 | -38.9% | 215,138 | +18.2% | 0.00% | 0.0% |
| Q4 2019 | $2,998,000 | +40.2% | 182,024 | +20.2% | 0.00% | 0.0% |
| Q3 2019 | $2,138,000 | +53.5% | 151,415 | +118.5% | 0.00% | +100.0% |
| Q2 2019 | $1,393,000 | +131.4% | 69,291 | +357.2% | 0.00% | 0.0% |
| Q1 2019 | $602,000 | -84.6% | 15,156 | -86.5% | 0.00% | -75.0% |
| Q4 2018 | $3,900,000 | +12.9% | 112,251 | +34.3% | 0.00% | +33.3% |
| Q3 2018 | $3,455,000 | +69.0% | 83,567 | +50.2% | 0.00% | +50.0% |
| Q2 2018 | $2,044,000 | -12.0% | 55,630 | -6.6% | 0.00% | 0.0% |
| Q1 2018 | $2,323,000 | +57975.0% | 59,568 | +25912.2% | 0.00% | – |
| Q4 2017 | $4,000 | +300.0% | 229 | +186.2% | 0.00% | – |
| Q3 2017 | $1,000 | -50.0% | 80 | -52.7% | 0.00% | – |
| Q2 2017 | $2,000 | -60.0% | 169 | -29.3% | 0.00% | – |
| Q1 2017 | $5,000 | -99.2% | 239 | -99.5% | 0.00% | -100.0% |
| Q4 2016 | $627,000 | +1234.0% | 44,153 | +1897.9% | 0.00% | – |
| Q3 2016 | $47,000 | -65.2% | 2,210 | -63.1% | 0.00% | – |
| Q2 2016 | $135,000 | -40.8% | 5,996 | -49.9% | 0.00% | – |
| Q1 2016 | $228,000 | +442.9% | 11,968 | +652.7% | 0.00% | – |
| Q4 2015 | $42,000 | -91.5% | 1,590 | -89.9% | 0.00% | – |
| Q3 2015 | $496,000 | +3442.9% | 15,772 | +5829.3% | 0.00% | – |
| Q2 2015 | $14,000 | -98.7% | 266 | -99.0% | 0.00% | -100.0% |
| Q1 2015 | $1,087,000 | +4080.8% | 26,151 | +2552.2% | 0.00% | – |
| Q4 2014 | $26,000 | – | 986 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $29,182,000 | 13.03% |
| Copernicus Capital Management, LLC | 50,000 | $778,000 | 12.27% |
| Antipodean Advisors LLC | 1,000,000 | $15,550,000 | 4.28% |
| BRIDGER MANAGEMENT, LLC | 1,325,188 | $20,607,000 | 1.92% |
| Redmile Group, LLC | 6,449,577 | $100,291,000 | 1.48% |
| MAVERICK CAPITAL LTD | 7,704,676 | $119,808,000 | 1.12% |
| Baupost Group | 8,477,488 | $131,825,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 116,900 | $1,818,000 | 0.93% |
| Trellus Management Company, LLC | 73,056 | $1,136,000 | 0.78% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $8,164,000 | 0.75% |